Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HN.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.20.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.19.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.58.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCMNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.42.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.22.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HW.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.72NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used